Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

December 8 2023 - In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease

In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease
FTC warns pharma companies on excessive drug patenting
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Medtronic backs away from EOFlow deal
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Asked to Detail Payments to Harvard Doctors by Senator

Bloomberg

Wednesday, March 4, 2009 - 7:54am

tags:

Pfizer, physician payments

Boston Scientific, Cordis Settle Infringement Suit

Bloomberg

Wednesday, March 4, 2009 - 7:53am

tags:

Cordis, Boston Scientific, stents, patents

Bristol-Myers Taps Andreotti

WSJ Online

Wednesday, March 4, 2009 - 7:52am

tags:

Bristol-Myers Squibb

Pfizer: Making It 'Leaner, Meaner, More Efficient'

Businessweek

Wednesday, March 4, 2009 - 7:51am

tags:

Teva gets expanded FDA approval for MS drug

Yahoo/AP

Tuesday, March 3, 2009 - 9:16pm

tags:

Teva Pharmaceuticals, FDA, multiple sclerosis, MS, Copaxone

Study: Other Drugs May Limit Plavix's Effectiveness

WSJ Online

Tuesday, March 3, 2009 - 9:13pm

tags:

Plavix, Bristol-Myers Squibb, Sanofi

Celgene Corporation: Take the Money and Run

Seeking Alpha

Tuesday, March 3, 2009 - 11:45am

tags:

Celgene, Revlimid, Vidaza, pipelines

King, Acura say FDA will rule on form of tamper-resistant instant-release oxycontin by June 30

Yahoo/AP

Tuesday, March 3, 2009 - 11:44am

tags:

King, Acura Pharmaceuticals, FDA, oxycontin, Acurox

Abraxis' Fourth-Quarter Letdown

Forbes

Tuesday, March 3, 2009 - 11:43am

tags:

earnings, companies

AstraZeneca Warned Japanese Doctors of Diabetes Link

Bloomberg

Tuesday, March 3, 2009 - 11:42am

tags:

Seroquel, diabetes

Tallying Harvard Medical School’s Drug-Industry Ties

WSJ Online

Tuesday, March 3, 2009 - 11:41am

tags:

pharma industry

Roche Gains as Genentech Talk Eases Price Concerns

Bloomberg

Tuesday, March 3, 2009 - 9:26am

tags:

Roche, buyouts, Genentech

Pfizer signs deal with Bausch & Lomb to co-promote several eye-care products in US

Yahoo/AP

Tuesday, March 3, 2009 - 9:25am

tags:

Pfizer, optical care, Bausch & Lomb

Par reports 4Q loss on restructuring, legal charge

Businessweek

Tuesday, March 3, 2009 - 8:59am

tags:

Par Pharmaceutical, earnings

Drug Cocktail May Slow Alzheimer's

WSJ Online

Tuesday, March 3, 2009 - 8:55am

tags:

Forest Labs, Alzheimer's disease, memantine, Namenda

Inspire Pharmaceuticals sets 2009 revenue outlook, cuts jobs to focus on key programs

Yahoo/AP

Tuesday, March 3, 2009 - 8:54am

tags:

Inspire, outlook, layoffs

Pfizer Expects To Become Top Drug Co In Japan After Merger

CNN Money

Tuesday, March 3, 2009 - 6:30am

tags:

Pfizer, Wyeth, Japan

Genentech May Produce as Many as 15 New Drugs by 2015

Bloomberg

Tuesday, March 3, 2009 - 6:28am

tags:

Genentech, pipelines, Roche, buyouts

Pfizer expands generic portfolio through Aurobindo deal

Marketwatch

Tuesday, March 3, 2009 - 6:27am

tags:

Pfizer, India, Aurobindo

Genentech: Roche Needs Us More

TheStreet.com

Monday, March 2, 2009 - 5:44pm

tags:

Genentech, Roche, buyouts

Pages

Latest CP Wire Articles

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

Latest Pharmagather Articles

Transforming Medication Access with the Next Generation of Patient Support Services

Drug Channels

The Year in AdComms – A Look Back at 2023

eye on fda

What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices

Drug Channels

Drug Wholesalers and Brand-Name Drug Prices: Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s

Drug Channels

How Direct-to-Consumer Rx Platforms Help Patient Support Programs Succeed

Drug Channels

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky

Drug Channels

Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform

Drug Channels

Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks

Drug Channels

Drug Channels Outlook 2024 (NEW Live Video Webinar)

Drug Channels